Escudier B - Search Results

1

A dose-finding study of gemcitabine and vinorelbine in advanced previously treated malignancies.

Delord JP, Raymond E, Chaouche M, Ruffie P, Ducreux M, Faivre S, Boige V, Le Chevalier T, Rixe O, Baudin E, Pautier P, Rodier JM, Chouaki N, Escudier B, Kayitalire L, Armand JP. Delord JP, et al. Among authors: escudier b. Ann Oncol. 2000 Jan;11(1):73-9. doi: 10.1023/a:1008352227275. Ann Oncol. 2000. PMID: 10690391 Free article. Clinical Trial.

2

[Treatment of metastatic malignant insulinomas. 2 cases].

Mounedji-Boudiaf L, Rougier P, Culine S, de Baere T, Lasser P, Escudier B, Ducreux M, Kaloustian E, Droz JP, Roche A. Mounedji-Boudiaf L, et al. Among authors: escudier b. Presse Med. 1995 May 27;24(19):894-6. Presse Med. 1995. PMID: 7638129 French.

3

Phase I study of prolonged low-dose subcutaneous recombinant interleukin-2 (IL-2) in patients with advanced cancer.

Angevin E, Valteau-Couanet D, Farace F, Dietrich PY, Lecesne A, Triebel F, Escudier B. Angevin E, et al. Among authors: escudier b. J Immunother Emphasis Tumor Immunol. 1995 Oct;18(3):188-95. doi: 10.1097/00002371-199510000-00007. J Immunother Emphasis Tumor Immunol. 1995. PMID: 8770775 Clinical Trial.

4

Should the number of pulmonary metastases influence the surgical decision?

Girard P, Spaggiari L, Baldeyrou P, Le Chevalier T, Le Cesne A, Escudier B, Filaire M, Grunenwald D. Girard P, et al. Among authors: escudier b. Eur J Cardiothorac Surg. 1997 Sep;12(3):385-91; discussion 392. doi: 10.1016/s1010-7940(97)00203-0. Eur J Cardiothorac Surg. 1997. PMID: 9332916

5

[Cancer of the kidney in the adult].

Delord JP, Alexandre J, Chevreau C, Escudier B. Delord JP, et al. Among authors: escudier b. Bull Cancer. 1998 Sep;(1 Suppl):4-15. Bull Cancer. 1998. PMID: 9817068 Review. French.

6

Combination interleukin-2 and doxorubicin in advanced adult solid tumors: circumvention of doxorubicin resistance in soft-tissue sarcoma?

Le Cesne A, Vassal G, Farace F, Spielmann M, Le Chevalier T, Angevin E, Valteau-Couanet D, Fizazi K, Cojean I, Llombard A, Tursz T, Escudier B. Le Cesne A, et al. Among authors: escudier b. J Immunother. 1999 May;22(3):268-77. doi: 10.1097/00002371-199905000-00010. J Immunother. 1999. PMID: 10335487 Clinical Trial.

7

Cytokines in metastatic renal cell carcinoma: is it useful to switch to interleukin-2 or interferon after failure of a first treatment? Groupe Français d'Immunothérape.

Escudier B, Chevreau C, Lasset C, Douillard JY, Ravaud A, Fabbro M, Caty A, Rossi JF, Viens P, Bergerat JP, Savary J, Négrier S. Escudier B, et al. J Clin Oncol. 1999 Jul;17(7):2039-43. doi: 10.1200/JCO.1999.17.7.2039. J Clin Oncol. 1999. PMID: 10561255 Clinical Trial.

8

Phase II trial of thalidomide in renal-cell carcinoma.

Escudier B, Lassau N, Couanet D, Angevin E, Mesrati F, Leborgne S, Garofano A, Leboulaire C, Dupouy N, Laplanche A. Escudier B, et al. Ann Oncol. 2002 Jul;13(7):1029-35. doi: 10.1093/annonc/mdf213. Ann Oncol. 2002. PMID: 12176780 Free article. Clinical Trial.

9

Recombinant adenovirus shedding after intratumoral gene transfer in lung cancer patients.

Griscelli F, Opolon P, Saulnier P, Mami-Chouaib F, Gautier E, Echchakir H, Angevin E, Le Chevalier T, Bataille V, Squiban P, Tursz T, Escudier B. Griscelli F, et al. Among authors: escudier b. Gene Ther. 2003 Mar;10(5):386-95. doi: 10.1038/sj.gt.3301928. Gene Ther. 2003. PMID: 12601393 Clinical Trial.

10

Exosomes for cancer immunotherapy.

Andre F, Escudier B, Angevin E, Tursz T, Zitvogel L. Andre F, et al. Among authors: escudier b. Ann Oncol. 2004;15 Suppl 4:iv141-4. doi: 10.1093/annonc/mdh918. Ann Oncol. 2004. PMID: 15477298 Free article. Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

551 results

Search Page

Filters